-
Sincaraz, Sabalenka and late nights: Australian Open storylines
-
Alcaraz career Grand Slam at 22 would be 'crazy' - Federer
-
Error-strewn Keys crashes out to Mboko in Australian Open warm-up
-
Dupont's Toulouse face must-win Sale meeting with Champions Cup hopes on the line
-
South Korean health insurer loses appeal against tobacco companies
-
Experts growing new skin for Swiss fire victims
-
'Silent crisis': the generation of Salvadorans deprived of a dad
-
Trump to host Venezuelan opposition leader sidelined by US
-
Taiwan's TSMC logs net profit jump on AI boom
-
The Bulgarian mechanic Kremlin propaganda keeps killing
-
New Zealand warned Pacific neighbour over oil smuggling 'shadow fleet'
-
Fatal back-to-back crane failures tied to same Thai firm: minister
-
Japan to make bid to host Rugby World Cup again in 2035
-
Sinner on semi-final collison course with Djokovic at Australian Open
-
Greenlanders torn between anxiety and relief after White House talks
-
Ledecky posts second-fastest 1500m free time ever in Pro Swim win
-
Asia markets mixed, oil falls after Trump's Iran comments
-
AI-created Iran protest videos gain traction
-
Five things to know about Uganda
-
Uganda votes under internet blackout and police crackdown
-
Dreams on hold for Rohingya children in Bangladesh camps
-
Canada's Carney in Beijing for trade talks with Chinese leaders
-
All Blacks fire coach Robertson less than two years before World Cup
-
Long-awaited EU-Mercosur trade pact set for signing
-
Trump embraces AI deepfakes in political messaging
-
A year of Trump: US health policy reshaped in RFK Jr's image
-
One year in, Trump shattering global order
-
Hit TV show 'Heated Rivalry' a welcome surprise for gay hockey community
-
Spanish singer Julio Iglesias prepares defence against abuse allegations: Hola! magazine
-
Actor McConaughey seeks to patent image to protect from AI
-
Musk's Grok barred from undressing images after global backlash
-
Hosts Morocco set up Senegal AFCON final showdown
-
A True Empowerer - AGFA HealthCare Radiates Imaging Innovation at ECR 2026
-
Chelsea paid for costly errors in Arsenal defeat, says Rosenior
-
Morocco beat Nigeria on penalties to reach Africa Cup of Nations final
-
Golden Globes viewership shrinks again
-
NASA reports record heat but omits reference to climate change
-
Real Madrid crash out of Copa del Rey at Albacete on Arbeloa debut
-
Trump says Iran killings stopped as US scales back Qatar base
-
Arsenal beat Rosenior's Chelsea in League Cup semi first leg
-
US stocks fall again as Iran worries lift oil prices
-
Inter extend Serie A lead to six points after Napoli slip
-
Bayern beat Cologne to move 11 points clear in Bundesliga
-
Mane takes Senegal past Egypt into final of his last AFCON
-
'Bridgerton' premieres in Paris promising 'Cinderella with a twist'
-
California begins probe of Musk's Grok over sexualized AI images
-
Astronauts set to leave ISS in first-ever medical evacuation
-
Napoli's stalemate with Parma opens door for Serie A leaders Inter
-
Denmark says White House talks failed to alter US designs on Greenland
-
Venezuela looking to 'new era' after Maduro ouster, says interim leader
Trump 'considering' push to reclassify marijuana as less dangerous
US President Donald Trump on Monday said his administration could push to loosen federal restrictions on marijuana, reclassifying it as a less dangerous drug.
"We are considering that," Trump told reporters after he was queried whether an executive order on the issue was being discussed.
"A lot of people want to see it, the reclassification, because it leads to tremendous amounts of research that can't be done unless you reclassify, so we are looking at that very strongly."
At the federal level, marijuana is currently classified as a Schedule I substance, in the same league as drugs like heroin and LSD. The government considers these drugs to have high abuse potential without accepted use for medical treatment.
But dozens of US states already have legal medical marijuana programs, and many also have approved its recreational use.
According to a recent Washington Post report, Trump is aiming to push for a reclassification to Schedule III -- substances that are considered to have medical value and less potential for abuse.
That class includes ketamine and anabolic steroids.
Rescheduling is not legalization or decriminalization -- but easing federal restrictions could have ripple effects, including lowering barriers to pursue research, as authorizing clinical studies on Schedule I substances can require many layers of approval.
It could also have major tax implications for companies that legally grow and sell cannabis.
The US president cannot unilaterally reclassify a drug. The Post reported that Trump is expected to sign an executive order directing federal agencies to pursue reclassification.
Joe Biden's administration had previously pursued reclassification, but efforts stalled and were not completed before Trump took office in early 2025.
The US has a patchwork of state-level regulations regarding the commercial distribution, recreational possession and personal cultivation of cannabis.
In small amounts it is already legal for recreational use in 24 US states as well as Washington DC.
X.Brito--PC